Drugs / bivalent oral poliovirus vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04576910 | Nov 2020 → Jun 2021 | poliomyelitis | Zhejiang Provincial Center for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bivalent oral poliovirus vaccine | “Sabin inactivated and bivalent oral poliovirus vaccine (sIPV, bOPV) were commonly used in China since 2016.” PMID 37283972 ↗ Mar 2023 |
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04576910 ↗ |
| Modality | Vaccine | “Sabin inactivated and bivalent oral poliovirus vaccine (sIPV, bOPV) were commonly used in China since 2016.” PMID 37283972 ↗ Mar 2023 |